These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10084747)

  • 1. Recovery of ceftazidime-resistant Klebsiella pneumoniae from pediatric liver and intestinal transplant recipients.
    Green M; Barbadora K
    Pediatr Transplant; 1998 Aug; 2(3):224-30. PubMed ID: 10084747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of an outbreak due to extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a pediatric intensive care unit transplant population.
    Rebuck JA; Olsen KM; Fey PD; Langnas AN; Rupp ME
    Clin Infect Dis; 2000 Dec; 31(6):1368-72. PubMed ID: 11096004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility pattern and prevalence of extended spectrum beta-lactamase (ESBLs) producing strains of Klebsiella pneumoniae from a major hospital in New Delhi.
    Grover SS; Sharma M; Pasha ST; Singh G; Lal S
    J Commun Dis; 2004 Mar; 36(1):17-26. PubMed ID: 16295682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
    Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution and dissemination of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: epidemiology and molecular report from the SENTRY Antimicrobial Surveillance Program (1997-2003).
    DiPersio JR; Deshpande LM; Biedenbach DJ; Toleman MA; Walsh TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jan; 51(1):1-7. PubMed ID: 15629222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical sources and prevalence of resistance to antimicrobials of Klebsiella pneumoniae strains in Trinidad.
    Orrett FA
    Saudi Med J; 2005 Nov; 26(11):1766-70. PubMed ID: 16311663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal spread of both oxyimino-cephalosporin- and cefoxitin-resistant Klebsiella pneumoniae isolates co-producing SHV-2a and DHA-1 beta-lactamase at a burns intensive care unit.
    Song W; Lee KM; Kim HS; Kim JS; Kim J; Jeong SH; Roh KH
    Int J Antimicrob Agents; 2006 Dec; 28(6):520-4. PubMed ID: 17095195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of ceftazidime-resistant Klebsiella pneumoniae in a large university hospital in Tel Aviv.
    Noy A; Orni-Wasserlauf R; Sorkine P; Siegman-Igra Y
    Isr Med Assoc J; 2000 Dec; 2(12):908-11. PubMed ID: 11344772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15.
    Lytsy B; Sandegren L; Tano E; Torell E; Andersson DI; Melhus A
    APMIS; 2008 Apr; 116(4):302-8. PubMed ID: 18397465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
    Duttaroy B; Mehta S
    Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of TEM and SHV beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran.
    Shahcheraghi F; Moezi H; Feizabadi MM
    Med Sci Monit; 2007 Nov; 13(11):BR247-250. PubMed ID: 17968291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nosocomial bacteremia and urinary tract infections caused by extended-spectrum beta -lactamase-producing Klebsiella pneumoniae with plasmids carrying both SHV-5 and TLA-1 genes.
    Alcantar-Curiel D; Tinoco JC; Gayosso C; Carlos A; Daza C; Perez-Prado MC; Salcido L; Santos JI; Alpuche-Aranda CM
    Clin Infect Dis; 2004 Apr; 38(8):1067-74. PubMed ID: 15095209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic characterisation of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from stem cell transplant patients in Tunisia.
    Abbassi MS; Torres C; Achour W; Vinué L; Sáenz Y; Costa D; Bouchami O; Ben Hassen A
    Int J Antimicrob Agents; 2008 Oct; 32(4):308-14. PubMed ID: 18620848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
    Koksal F; Ak K; Kucukbasmaci O; Samasti M
    Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome.
    Panhotra BR; Saxena AK; Al-Ghamdi AM
    Saudi Med J; 2004 Dec; 25(12):1871-6. PubMed ID: 15711657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefuroxime resistance in Klebsiella pneumoniae. Susceptibility to cefotaxime and ceftazidime despite production of ESBLs.
    Schumacher H; Skibsted U; Hansen DS; Scheibel J
    APMIS; 1997 Sep; 105(9):708-16. PubMed ID: 9350215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children.
    Zaoutis TE; Goyal M; Chu JH; Coffin SE; Bell LM; Nachamkin I; McGowan KL; Bilker WB; Lautenbach E
    Pediatrics; 2005 Apr; 115(4):942-9. PubMed ID: 15805368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
    Mosqueda-Gómez JL; Montaño-Loza A; Rolón AL; Cervantes C; Bobadilla-del-Valle JM; Silva-Sánchez J; Garza-Ramos U; Villasís-Keever A; Galindo-Fraga A; Palacios GM; Ponce-de-León A; Sifuentes-Osornio J
    Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.